SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

Micro Labs completes repeat studies and predicts drugs will be back on the market in autumn

Sandoz repeats tests and Teva pulls malaria pill as EMA calls for suspension of Semler trialled drugs

Sandoz is repeating bioequivalence studies and Teva is withdrawing an antimalarial after the EMA recommended that drugs trialled by Semler should be suspended.

Teewinot gets US patent for bioreactor used to make synthetic cannabinoid APIs

Teewinot Life Sciences has been granted a US patent for a bioreactor it uses to produce synthetic cannabinoids.

Recipharm: Q2 rev up on M&As, higher demand and anti-radiation med

Acquisitions, higher demand for sterile liquid processing and a surge in Thyrosafe orders helped Recipharm offset pricing pressure in Portugal and lower UK sales in Q2.

Roche getting under the skin of biosimilar competition

Subcutaneous versions of its biologic blockbusters - including Mabthera and Herceptin - will help protect against biosimilar competition, says Roche.

GSK to expand recall of antibiotics made at Worthing API unit

GSK will recall more antibiotics made at a UK API unit that has been offline since the US FDA raised contamination concerns last year.

update

US investor buys J&J's opiate API business and announces restructuring

SK Capital has rejigged the senior teams at opiate API maker Noramco and raw material supplier Tasmanian Alkaloids just weeks after buying the firms from Johnson & Johnson (J&J).

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...